tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XENE Stock Latest News

Xenon Sets Date for 2026 Annual Shareholder Meeting
Company AnnouncementsXenon Sets Date for 2026 Annual Shareholder Meeting
2d ago
8K
XENE
Xenon’s X-TOLE2 Trial Completion Puts XEN1101 in Focus for Epilepsy Investors
PremiumCompany Announcements
Xenon’s X-TOLE2 Trial Completion Puts XEN1101 in Focus for Epilepsy Investors
2d ago
XENE
Xenon Strengthens Balance Sheet With Major Equity Offering
PremiumCompany Announcements
Xenon Strengthens Balance Sheet With Major Equity Offering
3d ago
8K
XENE
Xenon Pharmaceuticals 10.5M share Spot Secondary priced at $57.00
PremiumThe Fly
Xenon Pharmaceuticals 10.5M share Spot Secondary priced at $57.00
4d ago
XENE
Xenon Raises $650 Million in Upsized U.S. Equity Offering
PremiumCompany Announcements
Xenon Raises $650 Million in Upsized U.S. Equity Offering
4d ago
XENE
Xenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy
PremiumRatingsXenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy
5d ago
XENE
Xenon Pharmaceuticals price target raised to $64 from $47 at Wedbush
Premium
The Fly
Xenon Pharmaceuticals price target raised to $64 from $47 at Wedbush
5d ago
XENE
Xenon Pharmaceuticals price target raised to $90 from $60 at Guggenheim
Premium
The Fly
Xenon Pharmaceuticals price target raised to $90 from $60 at Guggenheim
5d ago
XENE
Xenon Pharmaceuticals price target raised to $68 from $49 at Wells Fargo
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $68 from $49 at Wells Fargo
5d ago
XENE
Biohaven price target raised to $27 from $24 at Goldman Sachs
PremiumThe Fly
Biohaven price target raised to $27 from $24 at Goldman Sachs
5d ago
BHVN
XENE
Xenon Pharmaceuticals price target raised to $75 from $52 at Goldman Sachs
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $75 from $52 at Goldman Sachs
5d ago
XENE
Xenon Pharmaceuticals price target raised to $74 from $53 at H.C. Wainwright
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $74 from $53 at H.C. Wainwright
5d ago
XENE
Xenon Pharmaceuticals price target raised to $90 from $56 at Deutsche Bank
PremiumThe FlyXenon Pharmaceuticals price target raised to $90 from $56 at Deutsche Bank
5d ago
XENE
Xenon Pharmaceuticals Launches $500 Million Public Share Offering
Premium
Company Announcements
Xenon Pharmaceuticals Launches $500 Million Public Share Offering
6d ago
XENE
Xenon Pharmaceuticals announces $500M common shares offering
Premium
The Fly
Xenon Pharmaceuticals announces $500M common shares offering
6d ago
XENE
Xenon Pharmaceuticals price target raised to $100 from $65 at Jefferies
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $100 from $65 at Jefferies
6d ago
XENE
Xenon Pharmaceuticals price target raised to $80 from $59 at RBC Capital
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $80 from $59 at RBC Capital
6d ago
XENE
Raymond James says rival readout gives Biohaven’s Opakalim room to differentiate
PremiumThe Fly
Raymond James says rival readout gives Biohaven’s Opakalim room to differentiate
6d ago
BHVN
XENE
Xenon Pharmaceuticals: Blockbuster Potential for Azetukalner After Outperforming Phase 3 Epilepsy Data Drives Target Hike to $80
PremiumRatings
Xenon Pharmaceuticals: Blockbuster Potential for Azetukalner After Outperforming Phase 3 Epilepsy Data Drives Target Hike to $80
6d ago
XENE
Xenon Pharmaceuticals: Azetuklaner’s Strong Phase III Data and Blockbuster Potential Underscore Undervalued Buy Opportunity
PremiumRatingsXenon Pharmaceuticals: Azetuklaner’s Strong Phase III Data and Blockbuster Potential Underscore Undervalued Buy Opportunity
6d ago
XENE
Xenon Pharmaceuticals price target raised to $97 from $63 at Baird
Premium
The Fly
Xenon Pharmaceuticals price target raised to $97 from $63 at Baird
6d ago
XENE
Xenon Pharmaceuticals rises 46.5%
Premium
The Fly
Xenon Pharmaceuticals rises 46.5%
6d ago
XENE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >